Private equity · Private credit

Independent valuations for private markets.

Independent monthly and quarterly valuations for private equity and private credit — marked to the latest market data, defensible to your auditor.

Marked to market · IPEV · AASB 13 / IFRS 13 · AASB 9 / IFRS 9
Independent
Valuation report · illustrative

Senior Secured Facility — Fund A

Valuation date30 June
BasisFair value · AASB 13
Market data as of30 June
Every inputSourced & dated
Backed by a retained evidence file your auditor can follow.
Valued under IPEV Guidelines AASB 13 / IFRS 13 AASB 9 / IFRS 9 S&P Studies LSEG Market Data
Monthly revaluationStale valuation
now stale the stale gap JanFebMarAprMayJun
Why independent

Monthly, not stale.

A lagged statement holds an old number for months. A monthly valuation moves with the market — marked to the data as of your valuation date, never rolled forward.

Valuation, as practised, is broken for everyone who relies on it. So we rebuilt it around one idea: one independent, evidence-backed valuation per position — for your board, your auditors and your investors.

Auditors struggle with…

×Untraceable spreadsheet inputs
×Methods that drift year to year
×No evidence file behind the number

CFOs & trustees complain that…

×NAV strikes wait on manager statements
×Marks arrive a quarter late
×One number, no working shown
×Every audit question becomes a project

Investors are frustrated by…

×Smoothed, stale NAVs
×The manager marking its own book
×Surprises at exit
What we value

A concise, board-ready report.

One independent valuation per position — backed by a retained evidence file your auditor can follow.

Private equity

Private equity valuations

IPEV-aligned fair value for fund positions and directs, calibrated to current comparables.

Private credit

Private credit fair value

Loans and notes marked off current curves and credit spreads, with full sensitivity.

Ratings

Shadow credit ratings

An independent borrower rating from a weighted scorecard, calibrated to rating-agency studies.

Impairment

Impairment & ECL

AASB 9 / IFRS 9 staging and provisions, including default notes for positions under stress.

Empty boardroom overlooking a city skyline
One report, three audiences

For everyone who relies on the number.

For your board & IC, your auditors and your investors — the judgement documented, not implied, with no conflict because we hold no position.

For your board & IC

A NAV you can strike on schedule
The judgement documented, not implied
No conflict — we hold no position

For your auditors

Every figure traces to a named, dated source
Consistent method under a written policy
A retained evidence file per report

For your investors

Marks that move when markets move
Independent of the manager's incentives
Fewer surprises at exit

On your cycle

Monthly or quarterly — set once
Valuation date = market-data date
Delivered before your reporting deadline
Always current

Marked to today, not last quarter.

Market data as of the valuation date, every cycle — never rolled forward.

4
Typical manager statements / year
12
PM Vals, monthly cycle / year
How it works

One cycle, four steps.

Set the cadence once — monthly or quarterly. Every position is re-marked on the same date discipline, every cycle, without you chasing it.

Cycle
01 · You send the documents
Once per position.
deal documentsfinancialsinvestor updates
Then only the new material each cycle.
02 · We refresh the market data
Marked to your date.
curvesspreadscomparablescalibration
As of your valuation date — never rolled forward.
03 · Valuation, then adversarial QC
Re-computed, then challenged.
A second reviewer re-computes every figure before release.
04 · You receive the report
Board-ready.
▲ Retained evidence file, every cycle
Concise and defensible — delivered before your reporting deadline.
One cycle, four stepsIllustrative walkthrough
Glass office towers in early morning light
Why we built PM Vals

Valuation, rebuilt around evidence.

Untraceable inputs, methods that drift, NAVs that wait on manager statements, the manager marking its own book — the practice was broken for auditors, CFOs, trustees and investors alike.

We produce the independent valuation and evidence file your auditor reviews — which makes that review shorter, not longer.

Independent · Current · Defensible

Built for the people who sign the accounts.

Independent

No stake in the number

No position in the fund or the deal
One mandate: a mark you can defend
A second, adversarial reviewer on every report
Current

Marked to today, not last quarter

Market data as of the valuation date
Calibration refreshed from primary sources
Monthly or quarterly — your cycle, not ours
Defensible

Every figure shows its working

Each input traces to a named, dated source
Consistent method under a written policy
Retained evidence file behind every report
FAQ

Frequently asked questions

What standards do you value under?

IPEV for private equity; AASB 13 / IFRS 13 for fair value; AASB 9 / IFRS 9 for expected credit losses. Valuation date and report date are always the same date.

What assets do you cover?

PE fund positions and directs, and private credit in most forms — including structured and Islamic-finance facilities.

Monthly or quarterly?

Whichever matches your reporting. Every cycle is re-marked to current market data — never rolled forward.

What do you need from us?

Deal documents once, then each cycle's financials or investor updates. We source all market data ourselves.

Do you replace our auditor?

No — we produce the independent valuation and evidence file your auditor reviews. It makes that review shorter.

How is it priced?

A per-position, per-cycle fee agreed up front. No hourly billing.

See your book at today's value.

Send one position and a reporting date. We'll show you a current, defensible valuation.

or book a call — ben@pmvals.com